Published in Transplantation on July 15, 2010
Drug-drug interactions with oral anti-HCV agents and idiosyncratic hepatotoxicity in the liver transplant setting. J Hepatol (2013) 1.01
Fatal case of sorafenib-associated idiosyncratic hepatotoxicity in the adjuvant treatment of a patient with renal cell carcinoma. BMC Cancer (2012) 0.85
Sorafenib-induced liver failure: a case report and review of the literature. Case Reports Hepatol (2011) 0.84
Managements of recurrent hepatocellular carcinoma after liver transplantation: A systematic review. World J Gastroenterol (2015) 0.77
Outcomes of metastatic spinal cord compression secondary to primary hepatocellular carcinoma with multidisciplinary treatments. Oncotarget (2017) 0.75
Reduced exposure to calcineurin inhibitors in renal transplantation. N Engl J Med (2007) 9.44
Costimulation blockade with belatacept in renal transplantation. N Engl J Med (2005) 4.86
Architecture of the RNA polymerase II-TFIIF complex revealed by cross-linking and mass spectrometry. EMBO J (2010) 3.40
The protein composition of mitotic chromosomes determined using multiclassifier combinatorial proteomics. Cell (2010) 3.26
Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis. Nat Genet (2013) 1.83
Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein. Nat Biotechnol (2008) 1.70
Genome-wide association analysis in primary sclerosing cholangitis. Gastroenterology (2009) 1.69
Transplantation procedures in children with primary hyperoxaluria type 1: outcome and longitudinal growth. Transplantation (2009) 1.63
Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial. Liver Transpl (2002) 1.58
Safety, tolerability, and efficacy of everolimus in de novo liver transplant recipients: 12- and 36-month results. Liver Transpl (2006) 1.56
Pregnancy in primary sclerosing cholangitis. Gut (2011) 1.55
Heterozygous Arg753Gln polymorphism of human TLR-2 impairs immune activation by Borrelia burgdorferi and protects from late stage Lyme disease. J Immunol (2005) 1.49
Mental and physical quality of life in actual living liver donors versus potential living liver donors: a prospective, controlled, multicenter study. Liver Transpl (2009) 1.47
Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant. J Gastrointest Surg (2002) 1.45
Transfer of autologous gene-modified T cells in HIV-infected patients with advanced immunodeficiency and drug-resistant virus. Mol Ther (2007) 1.44
Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet (2010) 1.43
In vitro and in vivo proof of tolerance after two-step haploidentical bone marrow and kidney transplantation of the same donor. Transplantation (2012) 1.39
Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study. J Hepatol (2011) 1.36
Five-year safety and efficacy of belatacept in renal transplantation. J Am Soc Nephrol (2010) 1.31
Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci. J Hepatol (2012) 1.29
Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation (2002) 1.27
The diagnosis and treatment of cholangiocarcinoma. Dtsch Arztebl Int (2014) 1.25
Presence of EpCAM-positive circulating tumor cells as biomarker for systemic disease strongly correlates to survival in patients with hepatocellular carcinoma. Int J Cancer (2013) 1.23
FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation. Transplantation (2005) 1.21
Living donor liver transplantation. J Hepatol (2003) 1.18
Urinary ethyl glucuronide as a novel screening tool in patients pre- and post-liver transplantation improves detection of alcohol consumption. Hepatology (2011) 1.18
Combined targeting of AKT and mTOR synergistically inhibits proliferation of hepatocellular carcinoma cells. Mol Cancer (2012) 1.14
Viral features of lamivudine resistant hepatitis B genotypes A and D. Hepatology (2004) 1.13
Coactosin-like protein supports 5-lipoxygenase enzyme activity and up-regulates leukotriene A4 production. Proc Natl Acad Sci U S A (2006) 1.12
Evolution of donor morbidity in living related liver transplantation: a single-center analysis of 165 cases. Ann Surg (2004) 1.12
The problem of single parent/child paternity analysis--practical results involving 336 children and 348 unrelated men. Forensic Sci Int (2005) 1.11
Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4. Hepatology (2013) 1.11
A pharmacokinetic and clinical review of the potential clinical impact of using different formulations of cyclosporin A. Berlin, Germany, November 19, 2001. Clin Ther (2003) 1.10
Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9. Hepatology (2011) 1.09
Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma. Int J Cancer (2013) 1.09
Evaluation of use of Epstein-Barr viral load in patients after allogeneic stem cell transplantation to diagnose and monitor posttransplant lymphoproliferative disease. J Clin Microbiol (2002) 1.08
Extracellular signal-regulated kinases phosphorylate 5-lipoxygenase and stimulate 5-lipoxygenase product formation in leukocytes. FASEB J (2002) 1.07
Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis. PLoS One (2010) 1.07
Deficiency in virion secretion and decreased stability of the hepatitis B virus immune escape mutant G145R. Hepatology (2003) 1.02
Association of four DNA polymorphisms with acute rejection after kidney transplantation. Transpl Int (2008) 0.98
Living donor nephrectomy: flank incision versus anterior vertical mini-incision. Transplantation (2004) 0.95
FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation. Transplantation (2004) 0.95
Interleukin-2 receptor antagonist induction in modern immunosuppression regimens for renal transplant recipients. Transpl Int (2006) 0.95
Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: a prospective, randomized, multicenter trial. Liver Transpl (2009) 0.95
Long-term outcome of liver transplantation for autoimmune hepatitis. Clin Transplant (2004) 0.94
Attention and executive functioning deficits in liver-transplanted children. Transplantation (2010) 0.94
Safety and efficacy of protease inhibitor based combination therapy in a single-center "real-life" cohort of 110 patients with chronic hepatitis C genotype 1 infection. BMC Gastroenterol (2014) 0.94
Boswellic acids activate p42(MAPK) and p38 MAPK and stimulate Ca(2+) mobilization. Biochem Biophys Res Commun (2002) 0.93
Immunologic effector mechanisms of a standardized mistletoe extract on the function of human monocytes and lymphocytes in vitro, ex vivo, and in vivo. J Clin Immunol (2006) 0.91
One hundred thirty-two consecutive pediatric liver transplants without hospital mortality: lessons learned and outlook for the future. Ann Surg (2004) 0.91
3D CT modeling of hepatic vessel architecture and volume calculation in living donated liver transplantation. Eur Radiol (2003) 0.90
Hepatitis B virus immunization with an adjuvant containing vaccine after liver transplantation for hepatitis B-related disease: failure of humoral and cellular immune response. Transpl Int (2006) 0.90
Coactosin-like protein functions as a stabilizing chaperone for 5-lipoxygenase: role of tryptophan 102. Biochem J (2009) 0.90
Split liver transplantation and risk to the adult recipient: analysis using matched pairs. J Am Coll Surg (2002) 0.90
Armillifer armillatus pentastomiasis in African immigrant, Germany. Emerg Infect Dis (2013) 0.89
Proper estimation of blood loss on scene of trauma: tool or tale? J Trauma (2010) 0.89
Avoid "All-Touch" by Hybrid ALPPS to Achieve Oncological Efficacy. Ann Surg (2016) 0.88
Immediate postoperative intensive care treatment of pediatric combined liver-kidney transplantation: outcome and prognostic factors. Transplantation (2011) 0.87
Morbidity rate of reoperation in thyroid surgery: a different point of view. Swiss Med Wkly (2012) 0.87
FK778 in experimental xenotransplantation: a detailed analysis of drug efficacy. J Heart Lung Transplant (2007) 0.86
Selection of a secretion-incompetent mutant in the serum of a patient with severe hepatitis B. Gastroenterology (2003) 0.86
Neonates with severe infantile hepatic hemangioendothelioma: limitations of liver transplantation. Pediatr Transplant (2008) 0.86
Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms. Rev Med Virol (2012) 0.86
Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry. Liver Transpl (2010) 0.85
Subtype-dependent response of hepatitis B virus during the early phase of lamivudine treatment. Clin Infect Dis (2002) 0.85
Long-term outcome of split liver transplantation using right extended grafts in adulthood: A matched pair analysis. Ann Surg (2006) 0.85
Platelet activation and increased tissue factor expression on monocytes in reperfusion injury following orthotopic liver transplantation. Platelets (2010) 0.85
The selective estrogen receptor-beta agonist biochanin A shows vasculoprotective effects without uterotrophic activity. Menopause (2006) 0.85
Long-term Clinical Relevance of De Novo Donor-Specific Antibodies After Pediatric Liver Transplantation. Transplantation (2015) 0.85
Enzymatic production and complete nuclear magnetic resonance assignment of the sugar lactulose. J Agric Food Chem (2004) 0.84
High toxicity of sorafenib for recurrent hepatocellular carcinoma after liver transplantation. Transpl Int (2012) 0.84
Everolimus-induced pneumonitis: report of the first case in a liver transplant recipient and review of treatment options. Transpl Int (2009) 0.84
A new side effect of immunosuppression: high incidence of hearing impairment after liver transplantation. Liver Transpl (2006) 0.84
Identification of natural-product-derived inhibitors of 5-lipoxygenase activity by ligand-based virtual screening. J Med Chem (2007) 0.84
Cost-effectiveness analysis of antiviral treatment in liver transplant recipients with HCV infection. Transpl Int (2013) 0.84
Bowel wall hemorrhage after death by hanging. Int J Legal Med (2011) 0.84
The use of concentrated heat after insect bites/stings as an alternative to reduce swelling, pain, and pruritus: an open cohort-study at German beaches and bathing-lakes. Clin Cosmet Investig Dermatol (2011) 0.83
A prospective study on living related kidney donors' quality of life in the first year: choosing appropriate reference data. Clin Transplant (2012) 0.83
Long-term outcomes after liver transplantation for deoxyguanosine kinase deficiency: a single-center experience and a review of the literature. Liver Transpl (2014) 0.83
Clinical reactivation after liver transplantation with an unusual minor strain of hepatitis B virus in an occult carrier. Liver Transpl (2006) 0.83
RANTES and fibroblast growth factor 2 in jawbone cavitations: triggers for systemic disease? Int J Gen Med (2013) 0.83
Bladder tamponade due to vesical varices during orthotopic liver transplantation. Transpl Int (2008) 0.83